Pathology Review-Term1

99
“Find the key to yourself and every door in the world is open to you” Mother.. Know your Strengths, Weakness, Interests etc..

description

Medical School Pathology Review - Term1 Cardiovascular & Respiratory Systems.Video of this lecture is on youtube.

Transcript of Pathology Review-Term1

Page 1: Pathology Review-Term1

“Find the key to yourself and every door in the world

is open to you”Mother..

Know your Strengths, Weakness, Interests etc..

Page 2: Pathology Review-Term1

2013 Term 1 CPC 1 Title: Cardiovascular System 1/3 – Valvular Heart DiseaseSystem: Cardiovascular System

Aim: To train students in:Pathology, Clinical & population study of patients with valvular heart disease.

Objectives: 1. History taking & clinical examination of patient with valvular heart disease.

2. Physical examination - heart sounds both normal & abnormal.

3. Pathophysiology of common valve disorders (congenital & acquired) immune and developmental.

4. Review of basic sciences relating to embryogenesis of CVS system, immune system & autoimmunity.

5. Study of population & community/rural issues in rheumatic heart disease.

6. Understanding of cardiomyopathy (pathogenesis, common presentations)

7. Understanding of cyanotic and non-cyanotic congenital heart disease

Week learning overview:

Page 3: Pathology Review-Term1

2013 CPC-1.1

– Indigenous family from Cape York– one of seven children. Love sports.

• ‘Short winded’ since 6 months, worse since weeks, ‘heart pounding’, cough – no blood– Smokes 5 cigarettes/day, ‘gunja’ - occasional– Lives in a 4 bedroom house with 17 people *– fever & arthritis at 9y age*, off school for a month.– Brother gets injection every month since years *. – FH: Brother and mother have heart problems *...– Tall*, young*, JVP 4cm*.

Ms JM, 19-year-old woman living in a remote community who drops out of the local basketball team

Page 4: Pathology Review-Term1

Summary: ARF

Pancarditis + systemic(skin, joints, CNS)

Chronic RHD

Page 5: Pathology Review-Term1

ARF Microscopy: Aschoff body.

Aschoff Body

ARF- MicroscopyAschoff body

1. Necrosis2. Macrophages3. T Lymphocytes4. Giant cells(Near a BV)

ARF- GrossPancarditis

1. Fibrinous Pericarditis2. Myocarditis3. Endocarditis4. Valve Vegetations.

Page 6: Pathology Review-Term1

RHD: Clinical Correlations:

?

?

?

Page 7: Pathology Review-Term1

AT BIRTH (%)• Ventricular Septal Defect 42*• Atrial Septal Defect 10• Pulmonary Stenosis 8• Patent Ductus Arteriosus 7• Fallot’s Tetralogy 5• Coarctation Of Aorta 5

Adults % *ASD 47VSD 34FT 11COA 10

Congenital Heart Disease:

Classification:LR Shunts: ASD, VSD & PDA.RL Shunts: Fallot’s, Trans.GA.Obstructions: COA, PS.

Etiology: Toxic, Gen, infecPathogenesis: EmbryogenesisMorphology: Clinical:

Page 8: Pathology Review-Term1

Infective Endocarditis:

NON INFECTIVE VALVE DISORDERS:• Non bacterial thrombotic..NBTE – marantic.• Libman-Sacks endocarditis – autoimmune – APL sy.• Endocardial myofibrosis in Carcinoid syndrome.

Prosthetic valves – Mech/Bio, infec, thromb, hemolysis.

Intro: ABE- Staph, SBE- StrepEtiology: Abnormal valve, infecPathogenesis: EmbryogenesisMorphology: Valve destruction, bacterial growth.Clinical: Fever, flu, murmur, petechiae.

Page 9: Pathology Review-Term1

Aortic valve calcification:• most common cause of aortic

stenosis.• Etiology: calcification from

progressive age-associated "wear and tear".

• More in Congenital bicuspid aortic valve, Rheumatic (10%).

• Pathology:• Thick, irregular, fibrosed, with

nodules of calcification.• LVH & Failure. LVH

Page 10: Pathology Review-Term1

Cardiomyopathy:

• Intrinsic myocardial dysfunction, Primary structural abnorm.

• Congenital / Acquired.• Types:

– Dilated 90%– Hypertrophic– Restrictive.

10

Page 11: Pathology Review-Term1

“Some people grumble that roses have thorns; I am grateful

that thorns have roses.”-- Alphonse Karr

Look for good in others, no one is without faults & every one has some good quality!

Page 12: Pathology Review-Term1

2013 Term 1 CPC 2 Title: Cardiovascular System 2/4 – IHDSystem: Cardiovascular System

Aim: To train students in:Basic Pathology, clinical skills & population study of patients with ischaemic heart disease.

Objectives: 1. History taking & clinical examination of patient with Acute Coronary Syndrome (ACS).

2. Pathophysiology of ischaemic heart disease.3. Review of Basic sciences relating to CVS –

Anatomy, Physiology.4. Study of Population & community/rural issues

in life style associated diseases.

CPC12: Week overview:

Page 13: Pathology Review-Term1

CPC13-1.2 – Chest pain.

• While climbing steps* 15-20min, Pale, unwell, no pain now. Burning sensation in her neck.

• Similar episodes - 2y, more frequent now. Centre of sternum, no radiation*

• ↑Exertion, stress - ↓rest*• HPTN 15y, Dyslipidemia 8y, GORD 7y, • P/H: Chest pain, weak heart, no blocks.• F/H: Smoker, 1pack/day 25y, IHD, DM2,

Mrs. J.B 45 year old Aboriginal woman Presents for an urgent visit complaining of SOB, ‘oppressive feeling’ in her chest

Page 14: Pathology Review-Term1

Pathogenesis:1. intimal injury (at bifurcations)2. Inflammatory cells & macrophages.3. Lipid deposition, Central Necrosis,

more inflammation (soft plaque)4. Fibrosis, smooth muscle proliferation

(hard plaque)5. Complications – activaton, Thrombosis,

embolism, aneurism, dissection & rupture.

Page 15: Pathology Review-Term1

DANGER FACTORS• Low SMC.• Thin cap.• High Inflammation.• Large lipid core.

Plaque Biology:

Page 16: Pathology Review-Term1

Morphologic types:

Dots/streaks Soft Plaques Complicated Pl.

Page 17: Pathology Review-Term1

Atheroma types:

Page 18: Pathology Review-Term1

IHD Pathogenesis:

Stable

Unstable

Coronary block:

• <70% - Asymptomatic.

• >70-75% - Stable Angina

(exersion)

• 90% - Fixed stenosis (rest)

Chronic IHD

• Plaque change: (ACS)– Rupture, fissure, ulcer,

thromb/embolism.

– Unstable angina, MI / SCD

Page 19: Pathology Review-Term1

Common Sites:• Large BV : Aorta, Carotid & Iliac.

(large vessels) – Bruit.• Medium BV : Coronary,

Cerebral, Limbs, viscera – ischemia.

Why?

* AS never affects veins or small arteries.

* Microangiopathy is not due to AS

* AS is not a risk factor for DVT

* Alcohol is not a risk factor for AS.

* LDL is not bad type of cholesterol*

Page 20: Pathology Review-Term1

No Q wave - Q wave

Why spared?

Page 21: Pathology Review-Term1

What is important in this world is not where we are, but in which direction we are moving.

-- Oliver Wendell Holmes, Jr.

Page 22: Pathology Review-Term1

Location of MI & Involved Coronary A.

Page 23: Pathology Review-Term1

Morphology - Gross & Microscopic

Time (approx) GROSS MICROSCOPY

Up to 4 hour None None (loss of glycogen/LDH)

4 - 24 hours Gradually deepening dark area surrounded by erythema. Oedema.

Beginning coagulation necrosis contraction bands. Pyknotic nuclei, Oedema, few acute inflammatory cells.

3-7 days Pale / Yellow centre with haemorrhagic border

Obvious necrosis of muscle and plenty of Neutrophils hemorrhage (more if reperfusion injury) few macrophages.

1-3 weeks Pale, thin (loss of tissue mass) pale grey area with red border.

No muscle, Granulation tissue, macrophages prominent capillaries, fibroblasts.

3-6 weeks(permanent)

Small Silvery white scar . Replacement of granulation tissue by dense fibrosis

Page 24: Pathology Review-Term1

Myocardial Infarction: duration

Old & Recent

Page 25: Pathology Review-Term1

MI – stages.

Normal <1day Coagulative necrosis <7 days Acute inflam.

1-3 wk Granulation 3-6 wk Scar 3-6wk scar.

Page 26: Pathology Review-Term1

Complications of MI:

A Anterior myocardial rupture . B Rupture ventricular septum C Rupture papillary muscle. D Fibrinous pericarditis (dark, rough) E Thinning and mural thrombus. F aneurysm

Page 28: Pathology Review-Term1

2013 Term 1 CPC 3

Title: Cardiovascular 3/4 - PVD

System: Cardiovascular System, SkinAim: To train students in :

Clinical, Pathology & population study of patients with arterial + venous disorders + skin lesions.

Objectives: 1. History taking & clinical examination of patients with peripheral vascular disease

2. Clinical examination of peripheral circulation.3. Clinical examination of skin & skin lesions.4. Pathophysiology of common arterial and venous disorders.

Atherosclerosis & Deep vein thrombosis.5. Pathophysiology of common skin disorders Infection,

inflammation & malignancy. (Review MB3-TIN)6. Pathophysiology of Ischemia, infarction, and necrosis. (Review

MB3-TIN)7. Review of Basic sciences relating to structure and function of

blood vessels. Fluid balance and dynamics of micro capillary circulation & Pathophysiology of oedema formation.

8. Epidemiology of lifestyle diseases, population & community/rural issues in life style disorders specifically atherosclerosis.

Page 29: Pathology Review-Term1

Chronic leg ulcers: DD

• Venous : Varicose veins, Thrombophlebitis.

• Arterial : Atherosclerosis, Diabetes*.• Neuropathic : Diabetes*• Malignancy : BCC, SCC, MM• Infections : leprosy, TB, Treponemal, (Yaws)

• Others : Dermatitis, Vasculitis, Lymphedema..

Leg ulcers 1% Venous 80% - Arterial 10% * RACGP

Page 30: Pathology Review-Term1

Venous ulcers: (Wet, Bleeding, Dermatitis.

• Cause: Varicose veins.• Location: Gaiter region. • Features:

– large, irregular, shallow.– Wet edematous, oozing.– Moist granulating base – bleeds on

touch.– Surrounding eczematous stasis

dermatitis.– Mild pain, relieved by elevation. – Compression bandage helps.

Page 31: Pathology Review-Term1

Arterial Ulcers: (Dry & Painful)

• Cause: AS (PVD, DM2)• Location: distal & dorsal foot or toes.• Features:

– Cold, pale feet, absent or weak pulses. – Dry, Irregular clear border, grey black

necrotic. – Pale granulation, Does not bleed on

touch. – Painful (Nocturnal) partly relieved by

dependency.– Skin: Shiny, loss of hair – atrophy.

* Note: Angiogram, no compression bandage..

Page 32: Pathology Review-Term1

Neuropathic ulcers: (Clean, Caving, Callus)

• Cause: Nerve damage.• Location: Distal leg, pressure points.• Features:

– Punched-out ulcers, deep caving. – Frequently painless, loss or weak pulses. – Often with surrounding calluses

(hyperkeratosis)– Probing or debriding leads to brisk bleeding. – May also have Impaired sensation and

diminished positional sense or 2-point discrimination.

Page 33: Pathology Review-Term1

Malignant ulcers: (Exposed, tumour)

• Cause: UV-rays, Idiopathic.• Location: Sun exposed*.• Features: (remember ABCDE…!)

– irregular, Punched-out, deep, caving or with tumour.

– Frequently painless.– Lymphnodes, spreading, metastases.– Cancer cachexia – weight loss etc.

Page 34: Pathology Review-Term1

Infectious ulcers: multiple,

• Cause: TB, Treponema (Yaws, Pinta), etc.

• Location: not particular, multiple.• Features:

– irregular, non specific. – Lymphadenitis.

Page 35: Pathology Review-Term1

DVT: Typical Clinical History:• 34 year male – sudden chest pain and

collapse while recovering 12 days after orthopaedic surgery for comminuted # of femur.

• 68 year male AS, past MI, chest pain following 24 hour flight travel.

• 28 year female, recurrent abortions.• 54 year obese female, tender calf muscles.• Pregnancy, OCP, flight, surgery,

Page 36: Pathology Review-Term1

Risk Factors for DVT• Virchow’s triad: (Flow– Blood - Vessel)

– Stasis, Hypercoagulability & BV injury.

• Stasis (flow)– Immobilization, paralysis, in-patients, heart failure.

• Hypercoagulability (Blood):– Congenital: AT III, Protein-C/S deficiency, F V Leiden– Acquired: Lupus & anti cardiolipin anticoagulants, – Drugs, Oral contraceptives, Hyperhomocysteinemia.– Hyperviscosity – Polycythemia, paraproteins.

• Tissue damage (Vessel):– Surgery, Trauma, MI, Stroke, Malignancy, Phlebitis.

Page 37: Pathology Review-Term1

Varicose Veins:• Tortuous superficial veins due

to valve defect in deep veins of lower limb.

• Congenital / Acquired.• Tortuous prominent veins.• Gaiter region.• Thrombosis & ulceration.• Over Medial malleolus.• Note: No DVT* or PE*

Page 38: Pathology Review-Term1

Leg Veins & varicosity:

Page 39: Pathology Review-Term1

Common Immune Vasculitis:

Page 40: Pathology Review-Term1

Raynaud’s Phenomenon:• Vasoconstriction of digital arteries.• Cold/emotional trigger.• Primary: R.disease – genetic 3-5%• Secondary: Vasculitis, SLE, Buergers,

atherosclerosis, cold Ab hemolytic anemia etc.

Pallor Cyanosis

Page 41: Pathology Review-Term1

Polyarteritis nodosa:• Rare, Immune, HBs ag.• Systemic vasculitis with

necrotizing inflammation.• Nodules over arteries.• Acute fever, muscle & joint

pain, asymetric polyarthritis • Malaise rash & weight loss.• Neuropathy, kidney failure,.• High ESR, CRP, WBC.• Treat: Immunosuppression. Fibrin

oid NecrosisIn

flam

mato

ry cells

Page 42: Pathology Review-Term1

Wegener’s granulomatosis:

Granulomatous inflammation around small vessels with epitheloid cells and giant cells. Lung specimen showing cavitating grey white lesions. (similar to TB)

Page 43: Pathology Review-Term1

Buerger’s Disease:• Thromboangiitis

obliterans• Strong association with

smoking.• Common Males, Jews.• Peripheral gangrene• Small artery in limbs

thrombosis & fibrosis. • Also involves veins &

surrounding tissue.

Page 44: Pathology Review-Term1

Giant cell arteritis:

Aorta Temporal Art. Nodular segmental thickening, Most common in adults, T-cell Granuloma + Giant cells, Ophthalmic artery blindness

Page 45: Pathology Review-Term1

That person who declares that there is always something wrong is

always doing something to make things wrong.

— Christian Larson

Page 46: Pathology Review-Term1

CPC14: Week overview:2013 Term 1

CPC 4Title: Respiratory 1/3 - Pneumonia

System: Respiratory SystemAim: To train students in :

Clinical, Pathology & population study of patients with pneumonia COPD, and pneumoconiosis.

Objectives: 1. History taking & clinical examination of patients with a chronic lung disease (COPD, asthma, TB, fungal & other chronic infections) and acute infection (pneumonia).

2. Review of Basic sciences relating to structure and function of lungs. Blood gas physiology, measurement of blood gasses and lung function tests, sputum cytology and serology in lung infection.

3. Pathology of chronic obstructive airway disorders.4. Pathophysiology of acute respiratory infection.5. Pathophysiology of occupational, environmental & smoking related lung disorders. 6. Pathophysiology of common and important rare causes of pneumonia, particularly

tropical illnesses.7. Physical examination of Respiratory system.8. Complications of pneumonia. 9. Interpretation of Chest X-rays.10. Epidemiology of pneumonia in Australia, South East Asia and The Tropics.11. Role of health promotion, screening, public health in acute and chronic pneumonic

conditions.12. Smoking & lung disease. Role of health promotion, Population & community/rural

issues in smoking & work related lung disorders (pneumoconiosis).

Page 47: Pathology Review-Term1

Pneumonia

47

Pathogenesis of Pulmonary Infections

Aspiration, Inhalation, Inoculation, Colonization, Hematogenous & Direct spread

Page 48: Pathology Review-Term1

Pneumonia

48

Pneumonia Types:

Etiologic Types: Infective

Viral Bacterial Fungal Tuberculosis

Non Infective Toxins chemical Aspiration

Morphologic types: Lobar Broncho InterstitialDuration: Acute ChronicClinical: Primary /

secondary. Typical / Atypical Community a /

hospital a

Page 49: Pathology Review-Term1

Pneumonia

49

Types of Pneumonias & Causative agents

Community-Acquired Typical Pneumonia: Strep, H.influenzae, Staph aureus, Klebsiella.

Community-Acquired Atypical Pneumonia: Mycoplasma, Chlamydia, Legionella, SARS*, Q

Fever Nosocomial Pneumonia:

Klebsiella spp., Serratia, E coli, Pseudomonas Aspiration Pneumonia:

Anaerobic oral flora (Bacteroides) Chronic Pneumonia:

Nocardia, Actinomyces, Atyp. Mycob, Fungal (TB) Necrotizing Pneumonia and Lung

Abscess: Anaerobic bacteria

Pneumonia in the Immunocompromised: CMV, Pneumocystis, Atyp. Mycob. Fungal.

Page 50: Pathology Review-Term1

CongestionRed Hepatisation

Grey HepatizationResolution

Pathogenesis of Pneumonia

Page 52: Pathology Review-Term1

Pneumonia

52

Broncho – Pneumonia - Lobar

Extremes of age. Secondary, in sick. Both genders. Staph, Strep, H.infl. Patchy consolidation Around Small Bronchi Not limited by anatomic

boundaries. Usually bilateral.

Middle age – 20-50 Primary in a healthy adult. males common. 95% pneumococcus

(Klebs.) Entire lobe consolidation Diffuse Limited by anatomic

boundaries. Usually unilateral

Page 53: Pathology Review-Term1

Pneumonia

53

Chronic Pneumonia Chronic, lymphoid infiltrate, No classic stages. Lung destruction. Organisms

TB, Fungal etc.

Interstitial pneumonia

Viral

NON INFECTIVE PNEUMONIA:• Aspiration pneumonia

• Lower lobe, sec infection, abscess.

• Lipid pneumonia• Airway obstruction,

atelectasis.• Eosinophilic pneumonia

• Asthma, Löffler's syndrome.

Page 54: Pathology Review-Term1

The ability to concentrate and to use your time well is everything if you want to succeed in business, or anywhere else for that matter!-- Lee Iacocca

Page 55: Pathology Review-Term1

CPC15: Week overview:2013 Term 1 CPC 5 Title: Respiratory 2/2 - Asthma & COPD

System: Respiratory SystemAim: To train students in :

Clinical, Pathology and Population studies of patients with Upper Airway Disease Processes. Asthma, Chronic Cough, Emphysema, COPD, Chronic Bronchitis and Acute Bronchitis. [Epiglottitis, Croup]

Objectives:

1. History taking & clinical examination of patients with obstructive airway disease, upper airway disease.

2. Physical examination of Respiratory system.3. Review of Basic sciences relating to structure and

function of lungs. Blood gas physiology, measurement of blood gasses and lung function tests,

4. Pathophysiology of acute upper airway injury.

Page 56: Pathology Review-Term1

Pathogenesis of COPD

1. Smoke, irritants, carcinogens.

2. Tissue irritation & destruction

3. Inflam Mucous production.

4. Airway thickening narrowing.

5. Alveolar damage widening.• Increase in

– Alveolar marcrophages– CD8 Lymphocytes– Neutrophils– Proteases.

• Airway damage Bronchitis• Alveoli damage Emphysema.• Both COPD.

α1AT def.. Emphysema

Bronchitis Emphysema

Page 57: Pathology Review-Term1

Both affected commonly COPD

Page 58: Pathology Review-Term1

COPD: Overlap of Clinical syndromes

COPD

Page 59: Pathology Review-Term1

Normal - COPD

CB

Emphysema

Page 60: Pathology Review-Term1

Restrictive lung disorders:Definition: Reduced expansion.

A. Intrinsic Lung Disorders:– Sarcoidosis, pneumoconiosis.– TB, Interstitial Pneumonia

B. Extrinsic Dis. (chest wall):– Scoliosis, Kyphosis, Obesity,– Pleurisy, rib fracture etc.

C. Neuromuscular Disorders:– Paralysis of the diaphragm,

Myasthenia Gravis, Poliomyelitis.

Pathogenesis

Page 61: Pathology Review-Term1

Silicosis:• Inorganic – sand & stone

dust.• Toxic to macrophages –

destruction fibrosis.• Scattered multiple small,

fibrotic Nodules• Surrounding Irregular

emphysema.• Restrictive pattern of

PFT.

Page 62: Pathology Review-Term1

Asbestosis:• Asbestos bodies in sputum.

– (Protein & Hemosiderin)

• “Inconsumable”, Beaded 5-100mm x 0.25mm.

• Within alveoli at lung bases.• Dyspnoea, dry cough• Clubbing is common.• Diffuse effusion consolidation*,

fibrosis Honey comb lung.

Page 63: Pathology Review-Term1

Coal Miner’s Lung:• Athraco-Silicosis:• Dense cardon

pigmentation – Anthracosis and nodules of silicosis.

• Commonly seen in coal miners.

• Only anthracosis no fibrosis or damage.

Page 64: Pathology Review-Term1

Sarcoidosis:• Granulomatous, immune,

multisystem disorder. • Unknown Etiology.• Multiple fine nodules.• Like TB (no caseation).• Smokers – Uncommon• SOB, Erythema nodosum,

lymphadenopathy, hypercalcemia, nephrocalcinosis, occular, skin & nerve damage.. Etc.

• Stage I asymptomatic to Stage IV – Pulm fibrosis.

Page 65: Pathology Review-Term1

Restrictive vs Obstructive• Interstitial - (stiff lung)• Increased tissue •Relatively normal FEV1:FVC ratio

•Normal PEFR. •Types:•Acute – ARDS,Viral.•Chronic - pneumoconioses & sarcoidosis, Int. fibrosis.

•Obstructive (soft lung)•Destruction of tissue.•Low FEV1:VC ratio

•Low PEFR.•Types:

–Localised & Diffuse–Reversible & progressive.–COPD –Asthma–Bronchiectasis,

Page 66: Pathology Review-Term1

Asthma : Pathogenesis

Early phase (immediate) and late phase reactions

Page 67: Pathology Review-Term1

Asthma Morphology:

Asthma Microscopy1.Mucous Plugs +eosinophils2.Goblet cell hyperplasia3.Inflammation + Eosinophils4.Smooth muscle hyperplasia5.Mucous gl. Hyperplasia.

Page 68: Pathology Review-Term1

Lung Function Tests:

Page 69: Pathology Review-Term1

Whether you think that you can or that you can't,

you are usually right…!

– Henry Ford

Page 70: Pathology Review-Term1

CPC16: Week overview:2013 Term 1 CPC 6 Respiratory 3/3 – Lung cancer

System: Respiratory SystemAim: To train students in:

Clinical, pathological & population study of patients with lung cancer & smoking related lung diseases.

Objectives: 1. History taking & clinical examination of patients for chronic lung disease & smoking (COPD, cancer etc)

2. Physical examination of patient with respiratory symptoms.3. Pathophysiology of smoking related lung diseases.4. Pathophysiology of lung cancers.5. Review of basic sciences relating to structure and function of

lungs. Blood gas physiology, measurement of blood gases and lung function tests.

6. Pathophysiology of environmental & smoking related cancer development (carcinogenesis, chemical, radiation, viral etc.)

7. Epidemiology of smoking related disorders in Australia.8. Role of health promotion, population & community/rural issues

in smoking & work related lung disorders (pneumoconiosis).

Page 71: Pathology Review-Term1

Pathogenesis – Lung Cancer.

3pK-RasC-myc

p53

Irritation Carcinogens Initiation Promotion Ca.

Pathogenesis:1. Smoking – carcinogens2. 3p – tumor suppressor gene loss3. Mutations (p53, KRAS, EGFR..)4. Dysplasia5. Infiltration6. Spread7. Metastases.

Page 72: Pathology Review-Term1

Biology of Cancer:• Grading Differentiation Microscopic• Staging Progression Clinical - TNM

Low Grade high

• T – Tumor (T1-4)

• N – Node (N1-3)

• M – Metastasis (M0-1)

Stage

Page 73: Pathology Review-Term1

Lung tumors Classification:

• Bronchogenic Carcinoma: (95%)– Small cell carcinoma SCC 20%– Non Small Cell Carcinoma NSCC 80%

• Adeno carcinoma ~40%*• Squamous carcinoma ~35%• Large cell anaplastic ~5%

• Other Tumours (5%)– Bronchial Carcinoid Tumor– Lung Hamartoma

• Metastatis (more common)• Tumors of Pleura - Mesothelioma• Mediastinal Tumours

– Thymic & other Lymphoma, Teratoma.

SCCSq

Big 3

Ad

SCC NSCC

Page 74: Pathology Review-Term1

SCC Sq. Ca Ad. Ca

Page 75: Pathology Review-Term1

Common types of Lung Ca: Biopsy

Adeno carcinoma Squamous Ca. Small Cell CaPeripheral Central CentralLocalised Localised DiffuseFemale Males MalesNon smokers Smokers SmokersGlands Keratin Oat cellPale Blue Pink Dark Blue

Page 76: Pathology Review-Term1

Lung Ca – Cytology

Adeno carcinoma Squamous Ca. Small Cell CaGland formation Pink Cytoplasm little cytoplasmMucin Keratin nil

EGFR (bevacizumab) Epithelial marker NeuroendocrineALK, KRAS PTH-rp, ACTH, ADH, Calcitonin

Page 77: Pathology Review-Term1

Clinical features & complications.• Local:

– Obstruction– Effusion– Pneumonia* lipid, other.– Bronchiectasis– Atelectasis– Haemoptysis– COPD (risk)

• Systemic:– Cachexia– Paraneoplastic sy– Clubbing– Pulm. Osteoarthropathy.– Bone pain– CNS dysfunction

Page 78: Pathology Review-Term1

Carcinoid Tumour:

• Young <40y, • No relation to smoking. • Bronchus, Small polypoid submucosal (<4cm)• Neuroendocrine cells, secrete seratonin carcinoid

syndrome (intermittent attacks of diarrhea, flushing and cyanosis).

• behave benign even with nodal spread (no distant metastases).

• Uniform clusters with capillaries (endocrine pattern)

Page 79: Pathology Review-Term1

Mesothelioma:• 50% history of asbestos exposure.• Latent period of 25-40 years.• Preceded by pleural fibrous plaques.• Encases lungs from pleura.• Biphasic: (Carcinoma+Sarcoma)

Epithelial and fibrous components.

Page 80: Pathology Review-Term1

“A good scare is worth more to a man than good advice."

- Edgar Watson Howe - Country Town Sayings (1911)

That’s why we have…. Exams!

Page 81: Pathology Review-Term1

CPC17: Week overview:

2013 Term 1 CPC 7 Title: Cardiovascular System 4/4 – Hypertension & CCFSystem: Cardiovascular System

Aim: Clinical presentation, pathology and population studies of patients with Hypertension and Cardiac Failure.

Objectives: 1. History taking and Clinical examination of patients with hypertension.

2. Clinical examination of patients with Heart Failure.3. Pathophysiology of HT and CCF4. Anatomy of CVS5. Complications of Hypertension---CCF, AF, CVA, Renal

Failure, Retinal changes, Central vein thrombosis, Aortic Aneurysm and Aortic Dissection.

Page 82: Pathology Review-Term1

Blood Pressure:

82

(Aorta)

Cerebral / Coronary arteries

Resistant chamber

• Pressure = Pump + Resistance.• BP = Cardiac Output + BV. Res.• BP = CO + PR• Heart function, Blood volume, BV

elasticity control BP.• Kidney function important control.• Water*, Sodium* & BV tone*• Renin & Angiotensin system.

Measurements

BP

mmHg

• Pulse Pressure: 120-80 = 40 mmHg• Central Venous Pressure: 6 mmHg• Mean Arterial Pressure: DP+1/3PP = 93• Pulmonary Pressure: 20/10 mmHg• Cardiac Output: 4-8 L/min

Page 83: Pathology Review-Term1

Control of Blood Pressure:

83

Kidney BP Control:• Heart• Kidney• Hormones• Nerves

Page 84: Pathology Review-Term1

Complications: • BV thickening – Ischemia – Claudication.• Chronic, end organ & vascular damage.• Infarction(MI), Hemorrhage, Stroke & Aneurysm.

Page 85: Pathology Review-Term1

Heart Failure- PathophysiologyRenin Angiotensin Aldosterone BP & Fluid retention.

85

12

3

Low BloodLow GFR

High Fluid & High PR = High BP

Page 86: Pathology Review-Term1

Neurohormonal Mechanisms in HF

86

Inciting event

Page 87: Pathology Review-Term1

Hypertension

87

Page 88: Pathology Review-Term1

Ventricular Hypertrophy

88

LVH RVH

Systemic Hypertension Pulmonary Hypertension

>2 cm

Page 89: Pathology Review-Term1

Microangiopathy in Hypertension:• Hyaline arteriolosclerosis:

– Pink, hyaline thickening of vessel walls – narrowing of lumen

• Hyperplastic arteriolosclerosis:

– malignant hypertension : definition?– concentric laminated thickening of walls (“onion skin”) – Narrowing of lumen - smooth muscle proliferation

89

“onion skin”

Page 90: Pathology Review-Term1

Benign Nephrosclerosis

“Grain-leather kidney”

Hyaline arteriolosclerosis

Page 91: Pathology Review-Term1

Subarachnoid HaemorrhageIntracerebral haemorrhage (Stroke)

Hypertensive Intracranial haemorrhage

Page 92: Pathology Review-Term1

Hypertensive Retinopathy

• Grade I – Thickening of arterioles.

• Grade II – Focal Arteriolar spasms. Vein constriction. (AV nipping)

• Grade III – Hemorrhages (Flame shape), dot-blot and Cotton wool (ischemia) and hard waxy exudates (lipid deposition).

• Grade IV - Papilloedema

Page 93: Pathology Review-Term1

“Intelligence plus character, that is the goal of true education”

- Martin Luther King Jr.

Page 94: Pathology Review-Term1

Terminal cancer vs CHF

94

Worsening & compensatory mechanisms.

Page 95: Pathology Review-Term1

Compensatory Mechanisms:• Frank-Starling mechanism:

– More stretch – more contraction.• Neurohumoral activation:

– Vaso constrictors – norepinephrine– Renin-Angiotensin system.– Atrial Natriuretic Peptide – (opposite effect)

• Compensatory Hypertrophy of Heart:– Pathologic Hypertrophy:

• concentric, pressure, high mortality.

– Physiologic Hypertrophy• Eccentric, Volume, more BV, e.g. exercise.

95

Page 96: Pathology Review-Term1

LVF: Pulmonary odema, Brown induration

96“Heart-failure cells”

Brown induration of lung.

Page 97: Pathology Review-Term1

“To educate a person in the mind but not in morals is to educate a menace to society.”

-Theodore Roosevelt

Page 98: Pathology Review-Term1

“Identifying your Goal is like identifying the North Star, you fix your compass on it and then

use it as the means of getting back on track when you tend to stray”

-- Marshall Dimock

What am I doing? - Where am I going?(Where I want to be in 5 years?)

Page 99: Pathology Review-Term1

Wish you all Success, Health,

& Happiness in life.

Need help for exams? You can still contact me..